Light buckets and laser beams: mechanisms and applications of photobiomodulation (PBM) therapy.
Level 5 - mechanism / opinion, no new human data
Narrative review and workshop summary without systematic data pooling
PubMed 39826026 · doi:10.1007/s11357-025-01505-z
What was done
This paper reviews proceedings and literature updates from a 2023 National Institute on Aging workshop on photobiomodulation therapy. Participants evaluated proposed biological mechanisms of non-thermal, non-ionizing light therapy, including stimulation of mitochondrial cytochrome C oxidase, modulation of cell membrane transporters and receptors, and activation of transforming growth factor-beta-1, alongside potential applications for age-associated conditions.
What was found
The abstract reports no quantitative results or effect sizes. It summarizes expert consensus that photobiomodulation is a safe, promising therapeutic approach for conditions such as cardiovascular disease, retinal disease, Parkinson's disease, and cognitive impairment, while noting that mechanisms and treatment protocols still require optimization.
Why it matters
The paper outlines current expert consensus on the cellular targets and translational research directions for light-based therapy in aging biology.
Limits
This is a narrative workshop review rather than an empirical study or systematic review. The abstract provides no sample sizes, effect sizes, comparator data, or specific dosing parameters such as wavelengths or treatment durations.